Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopia
about
Systematic review of biomarkers to monitor therapeutic response in leishmaniasisGrowth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasisSuccessful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-γ, but not IL-10 ProductionLeishmania specific CD4 T cells release IFNγ that limits parasite replication in patients with visceral leishmaniasis.Protein energy malnutrition increases arginase activity in monocytes and macrophages.Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection.Phenotypic alteration of neutrophils in the blood of HIV seropositive patients.Inhibition of Leishmania (Leishmania) amazonensis and rat arginases by green tea EGCG, (+)-catechin and (-)-epicatechin: a comparative structural analysis of enzyme-inhibitor interactions.Characterization of neutrophil subsets in healthy human pregnancies.Increased plasma arginase activity in human sepsis: association with increased circulating neutrophils.M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis.Malnutrition in Healthy Individuals Results in Increased Mixed Cytokine Profiles, Altered Neutrophil Subsets and FunctionTranscriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.Expression of arginase I and inducible nitric oxide synthase in the peripheral blood and lymph nodes of HIV‑positive patients.Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions.Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in MacrophagesThe genetics of Leishmania virulence.The Phenotype of Circulating Neutrophils during Visceral Leishmaniasis.Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites.A Subset of Neutrophils Expressing Markers of Antigen-Presenting Cells in Human Visceral Leishmaniasis.l-Arginine Uptake by Cationic Amino Acid Transporter Promotes Intra-Macrophage Survival of Leishmania donovani by Enhancing Arginase-Mediated Polyamine Synthesis.M1 polarization and the effect of PGE2 on TNF-α production by lymph node cells from dogs with visceral leishmaniasis.Arginase activity in peripheral blood of patients with intestinal schistosomiasis, Wonji, Central Ethiopia.Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis.Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB/c Mice.Arginase I, Polyamine, and Prostaglandin E2Pathways Suppress the Inflammatory Response and Contribute to Diffuse Cutaneous LeishmaniasisAutophagic Induction Greatly Enhances Intracellular Survival Compared to in CBA/j-Infected MacrophagesMacrophage Polarization in Leishmaniasis: Broadening Horizons
P2860
Q26866450-8B56037E-7F2E-4EA5-B13D-A75A3875D1C5Q28540097-1181D335-07AC-4468-ADFA-39B939AD47BBQ28550696-9F82B784-74C5-474C-B66E-1F6866F03521Q34281875-FCB42A58-08CD-4EE4-92EC-CCAE4ECE00CCQ34492099-F4F4B6BA-1A77-42E0-818D-BC7747C1EA40Q34563619-26E4DE23-B4D4-448E-98FA-4838D097DE57Q34988287-DE7B1C53-1A8A-4F69-B037-D35A29211E7FQ35048063-24C5B4A2-B676-463B-8700-F2C50E91D6A5Q35097196-37DB3EB7-C99F-4D14-B100-770AD8AD2626Q35607212-18746040-BD31-4912-B0B6-49C133830242Q35819318-3E4F5AB2-50EB-4FB7-81F1-3BB2FE6765BCQ36109064-42F57073-B906-4873-8135-1639AE3557CAQ36265092-DBDF58EC-8BFC-41FF-9B12-769C151410F6Q36390189-5E23D12E-BF4D-4272-824D-8DD39103C73AQ37447272-D8D38F5A-45C3-48AA-A0C5-B0FFB54A5625Q38266887-96794E29-20CE-471B-969A-F972ABA77D3AQ38517526-C5D29FD2-50BD-4BC4-B77F-C704DE737F41Q38618438-798B8AC4-6E4E-42C8-9602-36B5041D8D88Q38667958-30C2831B-6A8A-4DE4-AA5F-1F51555FCBECQ39416012-CAD01BE7-FB9E-49D8-B653-B1C860AA2CE5Q40097757-3C8980BC-4C44-4066-AD9A-0B794CADF60FQ40480786-62BFB2C8-D54B-40CF-B7F9-2E0F8A10A2E9Q41414174-795255DB-709F-41A9-ADE6-3D6C35B17E1AQ46332681-C7FBF1D6-885E-4EEE-9D3A-59CFAAC5DD7FQ47098436-7A18B2BE-BE72-470F-98DA-1A69EC00BA20Q56798088-1277A7E4-B1B9-42A3-B511-9F228011337CQ58777346-53E4B21D-5B1E-41A6-B127-95CDAB3728B2Q59138115-54CB24F2-E8CC-414E-AB00-23F2CC1D5625
P2860
Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopia
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Arginase activity - a marker o ...... eral leishmaniasis in ethiopia
@ast
Arginase activity - a marker o ...... eral leishmaniasis in ethiopia
@en
Arginase activity - a marker o ...... eral leishmaniasis in ethiopia
@nl
type
label
Arginase activity - a marker o ...... eral leishmaniasis in ethiopia
@ast
Arginase activity - a marker o ...... eral leishmaniasis in ethiopia
@en
Arginase activity - a marker o ...... eral leishmaniasis in ethiopia
@nl
prefLabel
Arginase activity - a marker o ...... eral leishmaniasis in ethiopia
@ast
Arginase activity - a marker o ...... eral leishmaniasis in ethiopia
@en
Arginase activity - a marker o ...... eral leishmaniasis in ethiopia
@nl
P2093
P2860
P50
P1476
Arginase activity - a marker o ...... eral leishmaniasis in ethiopia
@en
P2093
Camille Corset
Ingrid Müller
Karina Corware
Manuel Modolell
Margaux Corset
Markus Munder
Pascale Kropf
Tamrat Abebe
Teklu Weldegebreal
P2860
P356
10.1371/JOURNAL.PNTD.0002134
P407
P577
2013-03-28T00:00:00Z